Heart failure patients see benefits from home-based rehab
Many heart failure patients still skip cardiac rehab altogether. Offering a home-based option could potentially help reverse that trend.
Related Articles
The CardioNerds, Dr. Kevin Alexander on the Impact of CV Hospitalizations in ATTR Cardiomyopathy | Docwire News
Dr. Georgia Vasilakis Tsatiris of The CardioNerds speaks to Dr. Kevin Alexander about the impact of ATTR-CM.
Diabetes reduces survival after SAVR, but not TAVR
“TAVR has been associated with better valve hemodynamics and a lower risk of structural valve deterioration over time compared with SAVR,” researchers wrote. “This benefit…
TAVR patients admitted on weekend face greater risk of death, complications
The so-called “weekend effect” seen with other cardiovascular diseases appears to exist for patients with severe aortic stenosis as well.
JACC | Priorities for Evidence Generation
In clinical practice, we frequently encounter critical questions for which we lack solid evidence. Whether on rounds or in the clinic, we often make decisions…
TIMD4hiMHCⅡhi Macrophages Preserve Heart Function Through Retnla:
Highlights •Genetic fate mapping has confirmed the existence of the TIMD4hiMHCIIhi macrophage subset, demonstrating that they were resident macrophages with minimal contribution from peripheral mon…
FDA warns that smartphone-compatible diabetes devices may not work properly
Smartphones have made it easier than ever for patients to monitor their own health, but the technology is far from infallible.
Update on the Proposed New Board of Cardiovascular Medicine | CV Board
On behalf of the proposed American Board of Cardiovascular Medicine (ABCVM) and our Board of Directors, I wanted to provide an update on the status…
Diagnosis and Management of Inadvertent Iliac Vein Injury During Structural Heart Interventions:
AbstractFemoral venous access is increasingly used by structural interventional cardiologists in procedures such as patent foramen ovale, atrial septal defect, and left atrial appendage closure,…
Clonal Hematopoiesis and Risk of Heart Failure After Autologous Hematopoietic Cell Transplantation for Lymphoma:
AbstractBackgroundPatients with lymphoma are at high risk for developing heart failure (HF) after autologous hematopoietic cell transplantation (HCT). More accurate risk determination pre-HCT may f…
New Trial to Test Novel Combination in Relapsed, Refractory MCL | Blood Cancers Today
Researchers are launching a new clinical trial that will evaluate the combination of the bispecific antibody glofitamab with the noncovalent BTK inhibitor pirtobrutinib in MCL.
